Treatment of bone metastases with denosumab in patients with non-squamous non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid
- Indications Bone metastases
- Focus Therapeutic Use
- 07 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.